Alteryx, Inc. (AYX) Touches $36.05 High on Mar, 2; Regeneron Pharmaceuticals Has 1.17 Sentiment

Retrieved on: 2018-03-02 01:48:45

Tags for this article:

Economy

Medicine

Monoclonal antibodies

Click the tags to see associated articles and topics

Alteryx, Inc. (AYX) Touches $36.05 High on Mar, 2; Regeneron Pharmaceuticals Has 1.17 Sentiment. View article details on hiswai:

Excerpt

<div>Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, makes, and commercializes medicines for the treatment of serious medical conditions worldwide. The company has market cap of $35.67 billion. The Company's products include EYLEA injection for the ...</div>

Article found on:

View Original Article